Save the date!

This distinguished event will convene leaders from across the biodefense industry, including investors, CEOs, founders, esteemed researchers, and policymakers.

Featuring an update on new office priorities from BTO Director Dr. Michael Koeris, a discussion of DARPA commercialization strategy, our expert panel discussions will focus on critical topics pertinent to early-stage biosecurity companies, including navigating early-stage funding, financing and exit trends, strategic partnerships with Department of Defense for growth, regulatory considerations, and innovations in biodefense development. We will host a reception after the main panels to conclude our discussions.

Please mark your calendar for this important event — we look forward to your participation!

Registration is scheduled to open in October 2025. By invitation only.​

Logistics:
Summit: 5-7 pm;
Reception: 7-10 pm.
Venue capacity is limited, all invites have to be approved by DARPA.